Paul Vaughan-Griffiths has been appointed to the newly created position of vice president of sales and marketing at Legacy Pharmaceuticals International, with the responsibility of overseeing sales and marketing in Europe, Middle East, Asia and Africa. He will be based at the company’s European headquarters in Basel, Switzerland.

“Legacy is excited to have Paul lead our EMEAA commercial efforts. We will continue to build on our momentum in the contract manufacturing business. This appointment underscores the depth of our commitment to global growth and continued profitability. The company will benefit from his expertise and leadership,” said Mr. Michael R. Danzi, Legacy’s chairman and chief executive officer.

Mr. Vaughan-Griffiths has more than 30 years’ experience in the pharmaceutical industry. Prior to joining Legacy he was head of commercial European operations in Prostrakan Ltd., where he was involved in building the European business. He also spent 10 years with Valeant Pharmaceuticals, where he was vice president sales, marketing and business development and helped build the European pharmaceutical business from $30 million to $250 million. He also spent 20 years working for American Cyanamid, Lederle Laboratories, in various sales, marketing and general management positions in Europe and the U.S.